MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-09-0014874
Pharmtech Solutions Private Limited
Pharmtech Solutions Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2019
₹10.59 Cr
▲ 397% YoY
Net profit · FY 2019
₹8.32 Lakh
Net margin 0.8%
EBITDA · FY 2019
₹37.45 Lakh
EBITDA margin 3.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹3.25 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings
About Pharmtech Solutions Private Limited
Data last updated:
Pharmtech Solutions Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24297TG2010PTC069743. Its GSTIN is 36AAFCP6222P2ZZ (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Bala Kumar Narsing Emmadabhoina and Bapanapalli Kummara Chandrasekhar.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Plot No.29B Phase – IV Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2019, the company reported a revenue of ₹10.59 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.32 Lakh (net margin 0.8%) and EBITDA of ₹37.45 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 116% over three years and 107% over five years.
As per MCA filings, the company has open charges of ₹3.25 Cr on record.
Pharmtech Solutions Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0014874). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24297TG2010PTC069743
Registration Number 069743
Incorporation Date 29 July 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-09-0014874
CIN history
Pharmtech Solutions has one previous CIN (Corporate Identification Number): U24297AP2010PTC069743. The current CIN is U24297TG2010PTC069743, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24297TG2010PTC069743 | Current |
| U24297AP2010PTC069743 | Previous |
Key People
Bala Kumar Narsing Emmadabhoina Additional Director Bapanapalli Kummara Chandrasekhar Additional Director Gaddam Kiranbabu Additional Director Recognitions & Rankings of Pharmtech Solutions
Contact details
Pharmtech Solutions Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.29B Phase – IV Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Pharmtech Solutions Private Limited, buy the company report.
Comprehensive company report
Pharmtech Solutions Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pharmtech Solutions is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pharmtech Solutions Private Limited, buy the company report.
Financials of Pharmtech Solutions Private Limited
FY 2019 filings availablePharmtech Solutions Private Limited reported revenue of ₹10.59 Cr (up 397% YoY) for FY 2019.
Revenue · FY 2019
₹10.59 Cr ▲ 397%
Net profit · FY 2019
₹8.32 Lakh margin 0.8%
EBITDA · FY 2019
₹37.45 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 397%
3 years · compounded
▲ 116%
5 years · compounded
▲ 107%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 11%
5 years · compounded
▲ 52%
Revenue has grown at a compounded annual rate (CAGR) of 107% over five years, including 397% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹10.59 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmtech Solutions Private Limited, buy the company report.
Board of directors of Pharmtech Solutions Private Limited
Pharmtech Solutions has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bala Kumar Narsing Emmadabhoina | Additional Director | 25 Mar 2021 | 5 Years 7 Months | Current |
| Bapanapalli Kummara Chandrasekhar Also directs: VRSP Exim India Private Limited | Additional Director | 25 Mar 2021 | 5 Years 7 Months | Current |
| Gaddam Kiranbabu Also directs: Zaampia Private Limited | Additional Director | 18 May 2025 | 1 Years 5 Months | Current |
Peer comparison
Pharmtech Solutions Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharm Products Private Limited | ₹10.64 Cr (FY 2025) | 8.0% | Thanjavur, Tamil Nadu, India | |||
| Vista Pharmaceuticals Ltd. | ₹10.62 Cr (FY 2024) | 657.0% | Telangana, India | |||
| Pharmtech Solutions Private Limitedthis company | ₹10.59 Cr (FY 2019) | ₹8.32 Lakh | 0.8% | 397.0% | Hyderabad, Telangana, India | |
| Salus Laboratories Private Limited | ₹10.59 Cr (FY 2024) | 45.0% | Madhura Nagar, Telangana, India | |||
| Biowin Healthcare Limited | ₹10.57 Cr (FY 2025) | -3.0% | Ahmedabad, Gujarat, India | |||
| Dallas Formulations Private Limited | ₹10.53 Cr (FY 2025) | 47.0% | Ujjain, Madhya Pradesh, India |
To see the full peer comparison of Pharmtech Solutions Private Limited, buy the company report.
Auditor
Pharmtech Solutions Private Limited is audited by S V S G & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S V S G & CO | FY 2019 | 015268S |
Shareholding
The shareholding of Pharmtech Solutions Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pharmtech Solutions Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.25 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Nov 2022 | 100646878 | Indian Overseas Bank | ₹2.5 Cr | Open | |
| 20 Jun 2012 | 10368086 | Others | ₹75.17 Lakh | Open |
To see the full charge records of Pharmtech Solutions Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Pharmtech Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmtech Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pharmtech Solutions has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCP6222P2ZZ | Telangana | Active | 23 Jul 2021 |
To see the full GST registrations and return filing status of Pharmtech Solutions Private Limited, buy the company report.
Recent activity
Pharmtech Solutions Private Limited has 15 board changes on record since 2012: 3 appointments and 12 cessations. The latest: Sameera Syed ceased to be Additional Director on 19 May 2025.
Ceased
Sameera Syed ceased to be Additional Director.
Appointed
Gaddam Kiranbabu was appointed as Additional Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 250.00 Lakh with Charge ID 100646878 was registered on 18 Nov 2022.
Ceased
Sudheer Karna Kankanala ceased to be Director.
Ceased
Nikhilasree Sriram Yadamani ceased to be Director.
Ceased
Aedula Srikanth ceased to be Director.
Appointed
Bala Kumar Narsing Emmadabhoina was appointed as Additional Director.
Appointed
Bapanapalli Kummara Chandrasekhar was appointed as Additional Director.
AGM
Pharmtech Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Ceased
Sai Ram Koushik Puranam ceased to be Director.
Ceased
Surender Kumar Puranam ceased to be Director.
Filing
Pharmtech Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad.
9 earlier events are in the company report.
Frequently asked questions
Pharmtech Solutions is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 July 2010 (16+ years old) and is registered under CIN U24297TG2010PTC069743.
Pharmtech Solutions has 3 current directors:
- Bala Kumar Narsing Emmadabhoina - Additional Director
- Bapanapalli Kummara Chandrasekhar - Additional Director
- Gaddam Kiranbabu - Additional Director
The latest financial statements of Pharmtech Solutions on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharmtech Solutions is 36AAFCP6222P2ZZ, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Pharmtech Solutions is U24297TG2010PTC069743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmtech Solutions was incorporated on 29 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Pharmtech Solutions by revenue are Pharm Products Private Limited, Vista Pharmaceuticals Ltd, Salus Laboratories Private Limited, Biowin Healthcare Limited, Dallas Formulations Private Limited, all in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sameera Syed ceased to be Additional Director on 19 May 2025. Gaddam Kiranbabu was appointed as Additional Director on 18 May 2025. Sudheer Karna Kankanala ceased to be Director on 16 Sep 2022. Pharmtech Solutions has 15 board changes on record in total.
Yes, Pharmtech Solutions is registered as a small enterprise under Udyam registration (number: UDYAM-TS-09-0014874).
The registered office of Pharmtech Solutions is at Plot No.29B Phase – IV Ida Cherlapally, Hyderabad, Telangana, India – 500051.
Pharmtech Solutions operates in the pharma industry, in the drug formulation and development segment.